Article Text

Download PDFPDF
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas
  1. Guillaume Le Guyader1,
  2. Victoire Vieillard1,
  3. Karine Andrieux2,
  4. Mylène Rollo1,
  5. Olivier Thirion1,
  6. Pierre Wolkenstein3,
  7. Muriel Paul1
  1. 1 Pharmacy Department, Henri Mondor Hospital Group, AP-HP, Creteil, France
  2. 2 Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), UMR CNRS 8258 U1022 INSERM, Université Paris Descartes, Paris, France
  3. 3 Department of Dermatology, Henri Mondor Hospital Group, AP-HP, Créteil, France
  1. Correspondence to Dr. Guillaume Le Guyader, Pharmacy Department, Henri Mondor Hospital Group, Créteil 94010, France; leguyader.guillaume{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.